- European Commission Approves Pfizer's PREVENAR 20® to Help Protect Infants and Children Against Pneumococcal Disease
- March 13, 2024
- Pfizer Announces Positive Overall Survival in Phase 3 Trial of ADCETRIS® Regimen in Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL)
- March 12, 2024
- Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference
- March 5, 2024
- Pfizer Oncology Hosts Innovation Day, Highlighting Fully Integrated Organization, Robust Portfolio, and Strategic Priorities to Drive Long-Term Sustainable Growth
- February 29, 2024
- Pfizer Announces Positive Top-Line Data for Full Season Two Efficacy of ABRYSVO® for RSV in Older Adults
- February 29, 2024
- Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference
- February 26, 2024